BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu Y, Sawalha AH, Lu Q. COVID-19 and autoimmune diseases. Curr Opin Rheumatol 2021;33:155-62. [PMID: 33332890 DOI: 10.1097/BOR.0000000000000776] [Cited by in Crossref: 46] [Cited by in F6Publishing: 120] [Article Influence: 46.0] [Reference Citation Analysis]
Number Citing Articles
1 Oshima K, Kanamori H, Takei K, Baba H, Tokuda K. Severe coronavirus disease 2019 in a patient with TAFRO syndrome: A case report. Clin Infect Pract 2022;16:100158. [PMID: 35919675 DOI: 10.1016/j.clinpr.2022.100158] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Sato T, Nihei R, Sora D, Nishio Y, Takeuchi M. Case report: Bilateral panuveitis resembling Vogt-Koyanagi-Harada disease after second dose of BNT162b2 mRNA COVID-19 vaccine. Front Immunol 2022;13:967972. [DOI: 10.3389/fimmu.2022.967972] [Reference Citation Analysis]
3 Zheng Q, Wang D, Lin R, Lv Q, Wang W. IFI44 is an immune evasion biomarker for SARS-CoV-2 and Staphylococcus aureus infection in patients with RA. Front Immunol 2022;13:1013322. [DOI: 10.3389/fimmu.2022.1013322] [Reference Citation Analysis]
4 Lu L, Liu L, Gui R, Dong H, Su Y, Zhou X, Liu F. Discovering common pathogenetic processes between COVID-19 and sepsis by bioinformatics and system biology approach. Front Immunol 2022;13:975848. [DOI: 10.3389/fimmu.2022.975848] [Reference Citation Analysis]
5 Velikova T. Vaccines and autoimmunity during the COVID-19 pandemic. World J Immunol 2022; 12(2): 9-14 [DOI: 10.5411/wji.v12.i2.9] [Reference Citation Analysis]
6 Rodríguez Y, Rojas M, Beltrán S, Polo F, Camacho-Domínguez L, Morales SD, Gershwin ME, Anaya JM. Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review. J Autoimmun 2022;132:102898. [PMID: 36041291 DOI: 10.1016/j.jaut.2022.102898] [Reference Citation Analysis]
7 Zhao Y, Zhao Y, Li M, Zhou Y, Zhang Y, Su X, Zhang Z, Jin L. Association of COVID-19 vaccination before conception with maternal liver function during early pregnancy: a cohort study of 7745 Chinese pregnant women. Emerg Microbes Infect 2022;:1-28. [PMID: 36000197 DOI: 10.1080/22221751.2022.2117100] [Reference Citation Analysis]
8 Knopf J, Sjöwall J, Frodlund M, Hinkula J, Herrmann M, Sjöwall C. NET Formation in Systemic Lupus Erythematosus: Changes during the COVID-19 Pandemic. Cells 2022;11:2619. [DOI: 10.3390/cells11172619] [Reference Citation Analysis]
9 Credle JJ, Gunn J, Sangkhapreecha P, Monaco DR, Zheng XA, Tsai H, Wilbon A, Morgenlander WR, Rastegar A, Dong Y, Jayaraman S, Tosi L, Parekkadan B, Baer AN, Roederer M, Bloch EM, Tobian AAR, Zyskind I, Silverberg JI, Rosenberg AZ, Cox AL, Lloyd T, Mammen AL, Benjamin Larman H. Unbiased discovery of autoantibodies associated with severe COVID-19 via genome-scale self-assembled DNA-barcoded protein libraries. Nat Biomed Eng 2022;6:992-1003. [DOI: 10.1038/s41551-022-00925-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Kihara M, Sugihara T, Asano J, Sato M, Kaneko H, Muraoka S, Ohshima S, Nanki T. Clinical characteristics of COVID-19 patients with underlying rheumatic diseases in Japan: data from a multicenter observational study using the COVID-19 Global Rheumatology Alliance physician-reported registry. Clin Rheumatol 2022. [PMID: 35974224 DOI: 10.1007/s10067-022-06305-w] [Reference Citation Analysis]
11 Tselmin S, Julius U, Jarzebska N, Rodionov R. COVID-19 and Therapeutic Apheresis. Horm Metab Res 2022;54:571-7. [PMID: 35944525 DOI: 10.1055/a-1864-9482] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Vahabi M, Ghazanfari T, Sepehrnia S. Molecular Mimicry, Hyperactive Immune System, And SARS-COV-2 Are Three Prerequisites of the Autoimmune Disease Triangle Following COVID-19 Infection. International Immunopharmacology 2022. [DOI: 10.1016/j.intimp.2022.109183] [Reference Citation Analysis]
13 Liu S, Zhao Y, Feng X, Xu H. SARS-CoV-2 infection threatening intestinal health: A review of potential mechanisms and treatment strategies. Crit Rev Food Sci Nutr 2022;:1-19. [PMID: 35894645 DOI: 10.1080/10408398.2022.2103090] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Al-Beltagi M, Saeed NK, Bediwy AS. COVID-19 disease and autoimmune disorders: A mutual pathway. World J Methodol 2022; 12(4): 200-223 [DOI: 10.5662/wjm.v12.i4.200] [Reference Citation Analysis]
15 Marjot T, Eberhardt CS, Boettler T, Belli LS, Berenguer M, Buti M, Jalan R, Mondelli MU, Moreau R, Shouval D, Berg T, Cornberg M. Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: an updated EASL position paper. J Hepatol 2022:S0168-8278(22)02942-7. [PMID: 35868584 DOI: 10.1016/j.jhep.2022.07.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Borghi MO, Bombaci M, Bodio C, Lonati PA, Gobbini A, Lorenzo M, Torresani E, Dubini A, Bulgarelli I, Solari F, Pregnolato F, Bandera A, Gori A, Parati G, Abrignani S, Grifantini R, Meroni PL. Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers. Front Immunol 2022;13:930074. [DOI: 10.3389/fimmu.2022.930074] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Anderle K, Machold K, Kiener HP, Bormann D, Hoetzenecker K, Geleff S, Prosch H, Laccone F, Heil PM, Petzelbauer P, Aletaha D, Blüml S, Kastrati K. COVID-19 as a putative trigger of anti-MDA5-associated dermatomyositis with acute respiratory distress syndrome (ARDS) requiring lung transplantation, a case report. BMC Rheumatol 2022;6:42. [PMID: 35821079 DOI: 10.1186/s41927-022-00271-1] [Reference Citation Analysis]
18 Al-Mustanjid M, Mahmud SH, Akter F, Rahman MS, Hossen MS, Rahman MH, Moni MA. Systems biology models to identify the influence of SARS-CoV-2 infections to the progression of human autoimmune diseases. Inform Med Unlocked 2022;:101003. [PMID: 35818398 DOI: 10.1016/j.imu.2022.101003] [Reference Citation Analysis]
19 Xie Y, Liu Y, Liu Y. The Flare of Rheumatic Disease After SARS-CoV-2 Vaccination: A Review. Front Immunol 2022;13:919979. [DOI: 10.3389/fimmu.2022.919979] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Qi H, Liu B, Wang X, Zhang L. The humoral response and antibodies against SARS-CoV-2 infection. Nat Immunol 2022;23:1008-20. [PMID: 35761083 DOI: 10.1038/s41590-022-01248-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Markarian NM, Galli G, Patel D, Hemmings M, Nagpal P, Berghuis AM, Abrahamyan L, Vidal SM. Identifying Markers of Emerging SARS-CoV-2 Variants in Patients With Secondary Immunodeficiency. Front Microbiol 2022;13:933983. [DOI: 10.3389/fmicb.2022.933983] [Reference Citation Analysis]
22 Melayah S, Mankaï A, Jemni M, Ben Chaben A, Ghozzi M, Ben Abdelkrim A, Ach K, Ghariani N, Denguezli M, Benzarti W, Benzarti M, Melayah S, Naija W, Ghedira I. Anti-Saccharomyces cerevisiae antibodies in patients with COVID-19. Arab Journal of Gastroenterology 2022. [DOI: 10.1016/j.ajg.2022.07.001] [Reference Citation Analysis]
23 Tonutti A, Motta F, Ceribelli A, Isailovic N, Selmi C, De Santis M. Anti-MDA5 Antibody Linking COVID-19, Type I Interferon, and Autoimmunity: A Case Report and Systematic Literature Review. Front Immunol 2022;13:937667. [DOI: 10.3389/fimmu.2022.937667] [Reference Citation Analysis]
24 Bigdelou B, Sepand MR, Najafikhoshnoo S, Negrete JAT, Sharaf M, Ho JQ, Sullivan I, Chauhan P, Etter M, Shekarian T, Liang O, Hutter G, Esfandiarpour R, Zanganeh S. COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes. Front Immunol 2022;13:890517. [PMID: 35711466 DOI: 10.3389/fimmu.2022.890517] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
25 Schultheiß C, Willscher E, Paschold L, Gottschick C, Klee B, Henkes SS, Bosurgi L, Dutzmann J, Sedding D, Frese T, Girndt M, Höll JI, Gekle M, Mikolajczyk R, Binder M. The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep Med 2022;3:100663. [PMID: 35732153 DOI: 10.1016/j.xcrm.2022.100663] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
26 Choung HYG, Jean-Gilles J, Goldman B. Subepithelial deposits with microspherular structures in membranous glomerulonephritis. Ultrastruct Pathol 2022;:1-11. [PMID: 35709324 DOI: 10.1080/01913123.2022.2090646] [Reference Citation Analysis]
27 Vojdani A, Vojdani E, Rosenberg AZ, Shoenfeld Y. The Role of Exposomes in the Pathophysiology of Autoimmune Diseases II: Pathogens. Pathophysiology 2022;29:243-80. [DOI: 10.3390/pathophysiology29020020] [Reference Citation Analysis]
28 Darmarajan T, Paudel KR, Candasamy M, Chellian J, Madheswaran T, Sakthivel LP, Goh BH, Gupta PK, Jha NK, Devkota HP, Gupta G, Gulati M, Singh SK, Hansbro PM, Oliver BGG, Dua K, Chellappan DK. Autoantibodies and autoimmune disorders in SARS-CoV-2 infection: pathogenicity and immune regulation. Environ Sci Pollut Res Int 2022. [PMID: 35657545 DOI: 10.1007/s11356-022-20984-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Vorster L, Kirk SE, Muscal E, Despotovic JM, Cohen CT, Sartain SE. COVID-19 vaccine (mRNA BNT162b2) and COVID-19 infection-induced thrombotic thrombocytopenic purpura in adolescents. Pediatr Blood Cancer 2022;69:e29681. [PMID: 35373880 DOI: 10.1002/pbc.29681] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Stappers S, van der Graaff D, Hoffman I, Moorkens W, Hantson I, Stappaerts I, Nowé V, Vervliet L. Systemic lupus erythematosus presenting as non-resolving pneumonia: a case report. Acta Clin Belg 2022;77:616-23. [PMID: 34027835 DOI: 10.1080/17843286.2021.1925817] [Reference Citation Analysis]
31 Tsukamoto Y, Umeda M, Muto Y, Sugimoto T, Yamauchi M, Ando K, Ariyoshi K. Severe Anemia Due to Cold Agglutinin Syndrome in a COVID-19 Patient with IgM Monoclonal Gammopathy of Undetermined Significance Successfully Treated with Corticosteroids. Intern Med 2022;61:1789-93. [PMID: 35342131 DOI: 10.2169/internalmedicine.8647-21] [Reference Citation Analysis]
32 Matyushkina D, Shokina V, Tikhonova P, Manuvera V, Shirokov D, Kharlampieva D, Lazarev V, Varizhuk A, Vedekhina T, Pavlenko A, Penkin L, Arapidi G, Pavlov K, Pushkar D, Kolontarev K, Rumyantsev A, Rumyantsev S, Rychkova L, Govorun V. Autoimmune Effect of Antibodies against the SARS-CoV-2 Nucleoprotein. Viruses 2022;14:1141. [PMID: 35746613 DOI: 10.3390/v14061141] [Reference Citation Analysis]
33 Floreani A, De Martin S. COVID-19 and Autoimmune Liver Diseases. J Clin Med 2022;11:2681. [PMID: 35628807 DOI: 10.3390/jcm11102681] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
34 Pakhchanian H, Khan H, Raiker R, Ahmed S, Kavadichanda C, Abbasi M, Kardeş S, Agarwal V, Aggarwal R, Gupta L. COVID-19 outcomes in patients with Dermatomyositis: a registry-based cohort analysis. Seminars in Arthritis and Rheumatism 2022. [DOI: 10.1016/j.semarthrit.2022.152034] [Reference Citation Analysis]
35 Arlotto S, Legueult K, Blin A, Cortaredona S, Giraud-Gatineau A, Bailly L, Jimeno MT, Delorme L, Brouqui P, Lagier JC, Million M, Dellamonica J, Colson P, Carles M, Raoult D, Pradier C, Gentile S. Who Were Hospitalized Deceased Patients from COVID-19 During the First Year of Pandemic? Retrospective Analysis of 1104 Deceased Patients in South of France. J Epidemiol Glob Health 2022. [PMID: 35486358 DOI: 10.1007/s44197-022-00039-3] [Reference Citation Analysis]
36 Tan SYT, Xiong J, Puar TH, Khoo J, Wong AJ, Soh SB, Supinski GS. Acute Flaccid Tetraparesis after COVID-19 Infection: Think of the Thyroid. Case Reports in Medicine 2022;2022:1-5. [DOI: 10.1155/2022/5827664] [Reference Citation Analysis]
37 Levy G, Guglielmelli P, Langmuir P, Constantinescu S. JAK inhibitors and COVID-19. J Immunother Cancer 2022;10:e002838. [PMID: 35459733 DOI: 10.1136/jitc-2021-002838] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
38 Hosseini P, Fallahi MS, Erabi G, Pakdin M, Zarezadeh SM, Faridzadeh A, Entezari S, Ansari A, Poudineh M, Deravi N. Multisystem Inflammatory Syndrome and Autoimmune Diseases Following COVID-19: Molecular Mechanisms and Therapeutic Opportunities. Front Mol Biosci 2022;9:804109. [DOI: 10.3389/fmolb.2022.804109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
39 Slurink IAL, Smaardijk VR, Kop WJ, Kupper N, Mols F, Schoormans D, Soedamah-Muthu SS. Changes in Perceived Stress and Lifestyle Behaviors in Response to the COVID-19 Pandemic in The Netherlands: An Online Longitudinal Survey Study. Int J Environ Res Public Health 2022;19:4375. [PMID: 35410055 DOI: 10.3390/ijerph19074375] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Das M, Ali A, Menon V. Hashimoto’s encephalopathy presenting as acute mania following recovery from COVID-19. Asian Journal of Psychiatry 2022. [DOI: 10.1016/j.ajp.2022.103115] [Reference Citation Analysis]
41 Taeschler P, Cervia C, Zurbuchen Y, Hasler S, Pou C, Tan Z, Adamo S, Raeber ME, Bächli E, Rudiger A, Stüssi-Helbling M, Huber LC, Brodin P, Nilsson J, Probst-Müller E, Boyman O. Autoantibodies in COVID-19 correlate with antiviral humoral responses and distinct immune signatures. Allergy 2022. [PMID: 35364615 DOI: 10.1111/all.15302] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
42 Aquino Ferraz LD, Marques NP, Silveira DMM, de Magalhães MJS, Oliveira EA, Martelli Júnior H. Assessment of Guillain-Barre Syndrome Cases in Brazil in the COVID-19 Era. Neurologist 2022. [PMID: 35350044 DOI: 10.1097/NRL.0000000000000406] [Reference Citation Analysis]
43 Zhu Y, Chen X, Liu X. NETosis and Neutrophil Extracellular Traps in COVID-19: Immunothrombosis and Beyond. Front Immunol 2022;13:838011. [PMID: 35309344 DOI: 10.3389/fimmu.2022.838011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 13.0] [Reference Citation Analysis]
44 Kang D, Na J, Yang J, Moon S, Kim S, Jung J, Cha H, Ahn J, Park Y, Cho S, Yu H, Lee S, Park M, Kim J, Byun J. Fulminant Giant Cell Myocarditis following Heterologous Vaccination of ChAdOx1 nCoV-19 and Pfizer-BioNTech COVID-19. Medicina 2022;58:449. [DOI: 10.3390/medicina58030449] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Lima M, Aloizou AM, Siokas V, Bakirtzis C, Liampas I, Tsouris Z, Bogdanos DP, Baloyannis SJ, Dardiotis E. Coronaviruses and their relationship with multiple sclerosis: is the prevalence of multiple sclerosis going to increase after the Covid-19 pandemia? Rev Neurosci 2022. [PMID: 35258237 DOI: 10.1515/revneuro-2021-0148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
46 Matsuo T, Sasai T, Nakashima R, Kuwabara Y, Kato ET, Murakami I, Onizawa H, Akizuki S, Murakami K, Hashimoto M, Yoshifuji H, Tanaka M, Morinobu A, Mimori T. ECG Changes Through Immunosuppressive Therapy Indicate Cardiac Abnormality in Anti-MDA5 Antibody-Positive Clinically Amyopathic Dermatomyositis. Front Immunol 2021;12:765140. [PMID: 35069538 DOI: 10.3389/fimmu.2021.765140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Sonigra KJ, Sarna K, Vaghela VP, Guthua S. An Interesting Case of Fatal Myasthenic Crisis Probably Induced by the COVID-19 Vaccine. Cureus 2022;14:e23251. [PMID: 35449619 DOI: 10.7759/cureus.23251] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
48 Usta NC, Kartal S, Gunay BO, Boz C. Neurological manifestations and etiological risk factors in patients hospitalized with COVID-19 in Turkey. Asian Biomedicine 2022;16:23-30. [DOI: 10.2478/abm-2022-0004] [Reference Citation Analysis]
49 Aghamirza Moghim Aliabadi H, Eivazzadeh‐keihan R, Beig Parikhani A, Fattahi Mehraban S, Maleki A, Fereshteh S, Bazaz M, Zolriasatein A, Bozorgnia B, Rahmati S, Saberi F, Yousefi Najafabadi Z, Damough S, Mohseni S, Salehzadeh H, Khakyzadeh V, Madanchi H, Kardar GA, Zarrintaj P, Saeb MR, Mozafari M. COVID‐19: A systematic review and update on prevention, diagnosis, and treatment. MedComm 2022;3. [DOI: 10.1002/mco2.115] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
50 Juanes-Velasco P, Landeira-Viñuela A, García-Vaquero ML, Lecrevisse Q, Herrero R, Ferruelo A, Góngora R, Corrales F, Rivas JL, Lorente JA, Hernández ÁP, Fuentes M. SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS. Front Immunol 2022;13:732197. [PMID: 35154090 DOI: 10.3389/fimmu.2022.732197] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
51 Kucher AN, Koroleva IA, Zarubin AA, Nazarenko MS. MicroRNAs as the Potential Regulators of SARS-CoV-2 Infection and Modifiers of the COVID-19 Clinical Features. Mol Biol 2022;56:29-45. [DOI: 10.1134/s0026893322010034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
52 Negahdaripour M, Rahbar MR, Mosalanejad Z, Gholami A, Tsantili Kakoulidou A. Theta-Defensins to Counter COVID-19 as Furin Inhibitors: In Silico Efficiency Prediction and Novel Compound Design. Computational and Mathematical Methods in Medicine 2022;2022:1-15. [DOI: 10.1155/2022/9735626] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
53 Wollanke B, Gerhards H, Ackermann K. Infectious Uveitis in Horses and New Insights in Its Leptospiral Biofilm-Related Pathogenesis. Microorganisms 2022;10:387. [PMID: 35208842 DOI: 10.3390/microorganisms10020387] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
54 Prabhahar A, Naidu GSRSNK, Chauhan P, Sekar A, Sharma A, Sharma A, Kumar A, Nada R, Rathi M, Kohli HS, Ramachandran R. ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based review. Rheumatol Int. [DOI: 10.1007/s00296-021-05069-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
55 Gusev E, Sarapultsev A, Solomatina L, Chereshnev V. SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19. Int J Mol Sci 2022;23:1716. [PMID: 35163638 DOI: 10.3390/ijms23031716] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 15.0] [Reference Citation Analysis]
56 Rath A, Reena R, Jose S. Anesthetic considerations in COVID-associated mucormycosis in a patient with autoimmune disorders. Minerva Anestesiol 2022;88. [DOI: 10.23736/s0375-9393.21.16070-5] [Reference Citation Analysis]
57 Raviv Y, Betesh-abay B, Valdman-grinshpoun Y, Boehm-cohen L, Kassirer M, Sagy I, Hsu TC. First Presentation of Systemic Lupus Erythematosus in a 24-Year-Old Male following mRNA COVID-19 Vaccine. Case Reports in Rheumatology 2022;2022:1-4. [DOI: 10.1155/2022/9698138] [Reference Citation Analysis]
58 Mouliou DS, Gourgoulianis KI. COVID-19 "asymptomatic" patients: an old wives' tale. Expert Rev Respir Med 2022. [PMID: 35041796 DOI: 10.1080/17476348.2022.2030224] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
59 Cheng ZJ, Li B, Zhan Z, Zhao Z, Xue M, Zheng P, Lyu J, Hu C, He J, Chen R, Sun B. Clinical Application of Antibody Immunity Against SARS-CoV-2: Comprehensive Review on Immunoassay and Immunotherapy. Clin Rev Allergy Immunol 2022. [PMID: 35031959 DOI: 10.1007/s12016-021-08912-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Connors C, McNeill S, Hrdlicka H. Occupational and Physical Therapy Strategies for the Rehabilitation of COVID-19 Related Guillain-Barré Syndrome in the Long-Term Acute Care Hospital Setting: A Case Report. JMIR Rehabil Assist Technol 2022. [PMID: 35023838 DOI: 10.2196/30794] [Reference Citation Analysis]
61 Hilado M, Banh M, Homans J, Partikian A. Pediatric Autoimmune Encephalitis Following COVID-19 Infection. J Child Neurol 2022;:8830738211069814. [PMID: 35014889 DOI: 10.1177/08830738211069814] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
62 Mathew S, Fakhroo AD, Smatti M, Al Thani AA, Yassine HM. Immunoinformatics prediction of potential immunodominant epitopes from human coronaviruses and association with autoimmunity. Immunogenetics 2022. [PMID: 35006282 DOI: 10.1007/s00251-021-01250-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Sinclair NRS. Beginnings of coinhibition. Scand J Immunol 2021;94:e13098. [PMID: 34940993 DOI: 10.1111/sji.13098] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
64 Mohammed S, Tripathi M, Mack N, Teelucksingh S. Relapse of Graves' disease following SARS‑CoV‑2 infection: A case report and brief literature review. Med Int 2021;1. [DOI: 10.3892/mi.2021.25] [Reference Citation Analysis]
65 Edwards K, Hussain I. Two Cases of Severe Autoimmune Thyrotoxicosis Following SARS-CoV-2 Infection. J Investig Med High Impact Case Rep 2021;9:23247096211056497. [PMID: 34844465 DOI: 10.1177/23247096211056497] [Reference Citation Analysis]
66 Finkenthal TA, Aldaher Z, Ahmed S, DiValentin L. Autoimmune Hemolytic Anemia Exacerbation Associated With COVID-19 Infection and Markedly Elevated Inflammatory Markers. Cureus 2021;13:e20416. [PMID: 35047256 DOI: 10.7759/cureus.20416] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Sapkota HR, Nune A. Long COVID from rheumatology perspective - a narrative review. Clin Rheumatol 2021. [PMID: 34845562 DOI: 10.1007/s10067-021-06001-1] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
68 Shahram F, Esalatmanesh K, Khabbazi A, Rezaieyazdi Z, Mirfeizi Z, Sadeghi A, Soroosh M, Kavosi H, Alikhani M, Mostafaei S. Coronavirus disease 2019 in patients with Behcet's disease: a report of 59 cases in Iran. Clin Rheumatol 2021. [PMID: 34842999 DOI: 10.1007/s10067-021-06004-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
69 Franchin G, Mantri N, Zahid M, Sun H, Gongati SR, Ronderos DM, Gadireddy S, Chilimuri S. Use of Monoclonal Antibodies Therapy for Treatment of Mild to Moderate COVID-19 in 4 Patients with Rheumatologic Disorders. Med Sci Monit 2021;27:e934267. [PMID: 34819488 DOI: 10.12659/MSM.934267] [Reference Citation Analysis]
70 Liu Y. Correspondence on 'Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients' by Trahtemberg et al. Ann Rheum Dis 2021:annrheumdis-2021-221711. [PMID: 34810196 DOI: 10.1136/annrheumdis-2021-221711] [Reference Citation Analysis]
71 Wang L, Li G, Yuan C, Yang Y, Ling G, Zheng J, Zhou Y, Zhang T, Lin W, Lin Z. Progress in the Diagnosis and Treatment of COVID-19 in Children: A Review. Int J Gen Med 2021;14:8097-108. [PMID: 34795516 DOI: 10.2147/IJGM.S335888] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
72 Karrow NA, Shandilya UK, Pelech S, Wagter-Lesperance L, McLeod D, Bridle B, Mallard BA. Maternal COVID-19 Vaccination and Its Potential Impact on Fetal and Neonatal Development. Vaccines (Basel) 2021;9:1351. [PMID: 34835282 DOI: 10.3390/vaccines9111351] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
73 Feghali EJ, Zafar M, Abid S, Santoriello D, Mehta S. De-Novo Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Following the mRNA-1273 (Moderna) Vaccine for COVID-19. Cureus. [DOI: 10.7759/cureus.19616] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
74 Drosos AA, Pelechas E, Voulgari PV. Seronegative Erosive Arthritis Following SARS-CoV-2 Infection. Rheumatol Ther 2021. [PMID: 34786669 DOI: 10.1007/s40744-021-00395-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
75 Avci E, Abasiyanik F. Autoimmune hepatitis after SARS-CoV-2 vaccine: New-onset or flare-up? J Autoimmun 2021;125:102745. [PMID: 34781161 DOI: 10.1016/j.jaut.2021.102745] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
76 Otaki JM, Nakasone W, Nakamura M. Self and Nonself Short Constituent Sequences of Amino Acids in the SARS-CoV-2 Proteome for Vaccine Development. COVID 2021;1:555-74. [DOI: 10.3390/covid1030047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
77 Shahidi Dadras M, Rakhshan A, Ahmadzadeh A, Hosseini SA, Diab R, Safari Giv T, Abdollahimajd F. Dermatomyositis-lupus overlap syndrome complicated with cardiomyopathy after SARS-CoV-2 infection: A new potential trigger for musculoskeletal autoimmune disease development. Clin Case Rep 2021;9:e04931. [PMID: 34667608 DOI: 10.1002/ccr3.4931] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
78 Sood A, Raghavan S, Batra P, Sharma K, Talwar A. Rise and exacerbation of oral lichen planus in the background of SARS-CoV-2 infection. Med Hypotheses 2021;156:110681. [PMID: 34601231 DOI: 10.1016/j.mehy.2021.110681] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
79 Mihalov P, Krajčovičová E, Káčerová H, Sabaka P. Lofgren syndrome in close temporal association with mild COVID-19 - Case report. IDCases 2021;26:e01291. [PMID: 34580630 DOI: 10.1016/j.idcr.2021.e01291] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
80 Friedman MA, Curtis JR, Winthrop KL. Impact of disease-modifying antirheumatic drugs on vaccine immunogenicity in patients with inflammatory rheumatic and musculoskeletal diseases. Ann Rheum Dis 2021;80:1255-65. [PMID: 34493491 DOI: 10.1136/annrheumdis-2021-221244] [Cited by in Crossref: 2] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
81 Simnica D, Schultheiß C, Mohme M, Paschold L, Willscher E, Fitzek A, Püschel K, Matschke J, Ciesek S, Sedding DG, Zhao Y, Gagliani N, Maringer Y, Walz JS, Heide J, Schulze-Zur-Wiesch J, Binder M. Landscape of T-cell repertoires with public COVID-19-associated T-cell receptors in pre-pandemic risk cohorts. Clin Transl Immunology 2021;10:e1340. [PMID: 34484739 DOI: 10.1002/cti2.1340] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
82 Saraceno JJF, Souza GM, Dos Santos Finamor LP, Nascimento HM, Belfort R Jr. Vogt-Koyanagi-Harada Syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine. Int J Retina Vitreous 2021;7:49. [PMID: 34462013 DOI: 10.1186/s40942-021-00319-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
83 Gelzo M, Cacciapuoti S, Pinchera B, De Rosa A, Cernera G, Scialò F, Comegna M, Mormile M, Gallicchio A, Fabbrocini G, Parrella R, Corso G, Gentile I, Castaldo G. A Transient Increase in the Serum ANCAs in Patients with SARS-CoV-2 Infection: A Signal of Subclinical Vasculitis or an Epiphenomenon with No Clinical Manifestations? A Pilot Study. Viruses 2021;13:1718. [PMID: 34578298 DOI: 10.3390/v13091718] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
84 Pascual-Iglesias A, Canton J, Ortega-Prieto AM, Jimenez-Guardeño JM, Regla-Nava JA. An Overview of Vaccines against SARS-CoV-2 in the COVID-19 Pandemic Era. Pathogens 2021;10:1030. [PMID: 34451494 DOI: 10.3390/pathogens10081030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
85 Bravo GÁ, Cirera LS, Torrentà LR. Clinical and radiological features of cerebral amyloid angiopathy-related inflammation. Neurol Sci 2021. [PMID: 34374865 DOI: 10.1007/s10072-021-05490-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Qureshi NK, Bansal SK. Autoimmune Thyroid Disease and Psoriasis Vulgaris after COVID-19 in a Male Teenager. Case Rep Pediatr 2021;2021:7584729. [PMID: 34354847 DOI: 10.1155/2021/7584729] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
87 Colatutto D, Sonaglia A, Zabotti A, Cereser L, Girometti R, Quartuccio L. Post-COVID-19 Arthritis and Sacroiliitis: Natural History with Longitudinal Magnetic Resonance Imaging Study in Two Cases and Review of the Literature. Viruses 2021;13:1558. [PMID: 34452422 DOI: 10.3390/v13081558] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
88 Batista CM, Foti L. Anti-SARS-CoV-2 and anti-cytokine storm neutralizing antibody therapies against COVID-19: Update, challenges, and perspectives. Int Immunopharmacol 2021;99:108036. [PMID: 34371330 DOI: 10.1016/j.intimp.2021.108036] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
89 Shabani Z. Demyelination as a result of an immune response in patients with COVID-19. Acta Neurol Belg 2021;121:859-66. [PMID: 33934300 DOI: 10.1007/s13760-021-01691-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
90 Alipoor SD, Mortaz E, Varahram M, Garssen J, Adcock IM. The Immunopathogenesis of Neuroinvasive Lesions of SARS-CoV-2 Infection in COVID-19 Patients. Front Neurol 2021;12:697079. [PMID: 34393976 DOI: 10.3389/fneur.2021.697079] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
91 Dreyer N, Petruski-Ivleva N, Albert L, Mohamed D, Brinkley E, Reynolds M, Toovey S. Identification of a Vulnerable Group for Post-Acute Sequelae of SARS-CoV-2 (PASC): People with Autoimmune Diseases Recover More Slowly from COVID-19. Int J Gen Med 2021;14:3941-9. [PMID: 34345182 DOI: 10.2147/IJGM.S313486] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
92 Dvornikova KA, Bystrova EY, Churilov LP, Lerner A. Pathogenesis of the inflammatory bowel disease in context of SARS-COV-2 infection. Mol Biol Rep 2021;48:5745-58. [PMID: 34296352 DOI: 10.1007/s11033-021-06565-w] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
93 Antonelli A, Fallahi P, Elia G, Ragusa F, Paparo SR, Mazzi V, Raimondo V, Ferrari SM, Ferri C. Effect of the COVID-19 pandemic on patients with systemic rheumatic diseases. Lancet Rheumatol 2021. [PMID: 34316725 DOI: 10.1016/S2665-9913(21)00243-5] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
94 Gray N, Lawler NG, Zeng AX, Ryan M, Bong SH, Boughton BA, Bizkarguenaga M, Bruzzone C, Embade N, Wist J, Holmes E, Millet O, Nicholson JK, Whiley L. Diagnostic Potential of the Plasma Lipidome in Infectious Disease: Application to Acute SARS-CoV-2 Infection. Metabolites 2021;11:467. [PMID: 34357361 DOI: 10.3390/metabo11070467] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
95 Quinn R, Murakhovskaya I. SARS-CoV-2 and Autoimmune Cytopenia. Hemato 2021;2:463-76. [DOI: 10.3390/hemato2030029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
96 Xu C, Fan J, Luo Y, Zhao Z, Tang P, Yang G, Pan Y, Guo S, Liu Y, Xiong Y, Xie W, Long X. Prevalence and Characteristics of Rheumatoid-Associated Autoantibodies in Patients with COVID-19. J Inflamm Res 2021;14:3123-8. [PMID: 34285538 DOI: 10.2147/JIR.S312090] [Reference Citation Analysis]
97 Veluswamy P, Wacker M, Stavridis D, Reichel T, Schmidt H, Scherner M, Wippermann J, Michels G. The SARS-CoV-2/Receptor Axis in Heart and Blood Vessels: A Crisp Update on COVID-19 Disease with Cardiovascular Complications. Viruses 2021;13:1346. [PMID: 34372552 DOI: 10.3390/v13071346] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
98 Zhang P, Bu Y, Jiang P, Shi X, Lun B, Chen C, Syafiandini AF, Ding Y, Song M. Toward a Coronavirus Knowledge Graph. Genes (Basel) 2021;12:998. [PMID: 34209818 DOI: 10.3390/genes12070998] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
99 Lung T, Sakem B, Hemmerle A, Nydegger M, Risch M, Risch L, Nydegger U. Autoimmune diseases - New insights into a troublesome field. J Transl Autoimmun 2021;4:100108. [PMID: 34179743 DOI: 10.1016/j.jtauto.2021.100108] [Reference Citation Analysis]
100 Fineschi S. Case Report: Systemic Sclerosis After Covid-19 Infection. Front Immunol 2021;12:686699. [PMID: 34262566 DOI: 10.3389/fimmu.2021.686699] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
101 Garg M, Maralakunte M, Garg S, Dhooria S, Sehgal I, Bhalla AS, Vijayvergiya R, Grover S, Bhatia V, Jagia P, Bhalla A, Suri V, Goyal M, Agarwal R, Puri GD, Sandhu MS. The Conundrum of 'Long-COVID-19': A Narrative Review. Int J Gen Med 2021;14:2491-506. [PMID: 34163217 DOI: 10.2147/IJGM.S316708] [Cited by in Crossref: 1] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
102 Castano-Jaramillo LM, Yamazaki-Nakashimada MA, O'Farrill-Romanillos PM, Muzquiz Zermeño D, Scheffler Mendoza SC, Venegas Montoya E, García Campos JA, Sánchez-Sánchez LM, Gámez González LB, Ramírez López JM, Bustamante Ogando JC, Vásquez-Echeverri E, Medina Torres EA, Lopez-Herrera G, Blancas Galicia L, Berrón Ruiz L, Staines-Boone AT, Espinosa-Padilla SE, Segura Mendez NH, Lugo Reyes SO. COVID-19 in the Context of Inborn Errors of Immunity: a Case Series of 31 Patients from Mexico. J Clin Immunol 2021. [PMID: 34114122 DOI: 10.1007/s10875-021-01077-5] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
103 Martelli Júnior H, Gueiros LA, de Lucena EG, Coletta RD. Increase in the number of Sjögren's syndrome cases in Brazil in the COVID-19 Era. Oral Dis 2021. [PMID: 34042242 DOI: 10.1111/odi.13925] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
104 Buyansky D, Fallaha C, Gougeon F, Pépin MN, Cailhier JF, Beaubien-Souligny W. Acute Tubulointerstitial Nephritis in a Patient on Anti-Programmed Death-Ligand 1 Triggered by COVID-19: A Case Report. Can J Kidney Health Dis 2021;8:20543581211014745. [PMID: 34046182 DOI: 10.1177/20543581211014745] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Nasonov EL. 2019 Coronavirus disease (COVID-19): contribution of rheumatology. Terapevticheskii arkhiv 2021;93. [DOI: 10.26442/00403660.2021.05.200799] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Watad A, De Marco G, Mahajna H, Druyan A, Eltity M, Hijazi N, Haddad A, Elias M, Zisman D, Naffaa ME, Brodavka M, Cohen Y, Abu-Much A, Abu Elhija M, Bridgewood C, Langevitz P, McLorinan J, Bragazzi NL, Marzo-Ortega H, Lidar M, Calabrese C, Calabrese L, Vital E, Shoenfeld Y, Amital H, McGonagle D. Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination. Vaccines (Basel) 2021;9:435. [PMID: 33946748 DOI: 10.3390/vaccines9050435] [Cited by in Crossref: 15] [Cited by in F6Publishing: 103] [Article Influence: 15.0] [Reference Citation Analysis]
107 Nasonov EL. Coronavirus disease 2019 (COVID-19) and autoimmunity. Naučno-praktičeskaâ revmatologiâ 2021;59:5-30. [DOI: 10.47360/1995-4484-2021-5-30] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 14.0] [Reference Citation Analysis]
108 Leso V, Fontana L, Iavicoli I. Susceptibility to Coronavirus (COVID-19) in Occupational Settings: The Complex Interplay between Individual and Workplace Factors. Int J Environ Res Public Health 2021;18:1030. [PMID: 33503829 DOI: 10.3390/ijerph18031030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]